Contact
 

HIV Prevention Trials In Infants Meeting Presentations

22 January

length

Item

Lead/speaker

08:30-08:40

Welcome and logistics                                            

Yegor Voronin

08:40-09:10

The need for new prevention modalities  

Lynne Mofenson

09:10-09:40

  Implementing PMTCT: Situation on the ground  

Godfrey Esiru

09:40-10:10

Use of immunization strategies to prevent HIV infection in neonates - what have we learned?  

Coleen Cunningham

10:10-10:40

Preclinical studies of passive immunization in neonate macaques  

J. Pablo Jaworski

Case study: Proposed trial of passive immunization with VRC01 antibody

11:00-11:20

VRC01 Antibody  

John Mascola

11:20-11:45

VRC01: Path to the clinic  

Barney Graham

11:45-12:15

Overview of the VRC01 trial  

Betsy McFarland

13:15-13:40

Introduction into the issues  

Jeff Safrit

13:40-15:40

Breakout groups

  • Logistical challenges (populations, incidence). Chair: Mary Glenn Fowler
  • Treatment and providing standard-of-care. Chair:  Chewe Luo
  • Ethical challenges. Chair: Hoosen “Jerry” Coovadia
  • Future prevention strategies – other monoclonal antibodies and vaccine. Chair: Pontiano Kaleebu

All/Subgroup Moderators and Rapporteurs

 

 

16:00-17:00

Reports from breakout groups (15 min each)

Subgroup Moderators/Rapporteurs

17:00

Adjourn

 

 

23 January

08:30-09:00

Other potential prevention modalities 

 

Tom Hanke

09:00-10:00

Subgroups reconvene, perhaps in a different composition

All/Subgroup Moderators/Rapporteurs

10:20-11:00

Reports from Subgroups (10 min each)

Subgroup Rapporteurs

11:00-12:30

General discussion

Helen Rees

12:30 - 12:40 Thanks from the VRC01 Development Team: What We Have Heard  Barney Graham

12:40-13:00

Summary and Next steps

Jeff Safrit

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account